Clinical trials show an average weight loss of around 21%
Journal of Autism and Developmental Disorders, 48 (8), 27662778
*Correspondence: Joo Sargento-Freitas [email protected] This article was submitted to Stroke, a section of the journal Frontiers in Neurology These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
This apparent discrepancy is not uncommon for this type of compound as similar results have been previously reported for ellagic acid, which displays 100 fold higher potency against parasites than against the purified GST enzyme, with a Ki of 74 M in an enzyme assay but an EC 50 of 0.8 M in antiparasitic assays (Sturm et al., 2009)
Some people may also experience sensitivities to inactive ingredients or certain formulations, which makes professional guidance especially important
Plaintiffs argue that the manufacturer aggressively marketed Ozempic and other GLP-1 drugs as transformative weight loss treatments while minimizing reports of serious side effects